Browse by Series:

FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year

Gina Columbus
Published Online: Thursday, Feb 09, 2017



Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
Slider Left
Slider Right


Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Updates from Singapore: Advances in Personalized Lung Cancer TreatmentFeb 28, 20171.5
Community Practice Connections™: 10th Annual New York Lung Cancer Symposium®Feb 28, 20173.0
Publication Bottom Border
Border Publication